OMC
LEGN icon

Old Mission Capital’s Legend Biotech LEGN Stock Holding History

Old Mission Capital’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,927
Closed -$518K – 1114
2024
Q4 		$518K Sell
15,927
-486
-3% -$20.1K 0.01% 597
2024
Q3 		$800K Buy
+16,413
New +$874K 0.01% 567
2024
Q2 		– Sell
-14,230
Closed -$798K – 1532
2024
Q1 		$798K Buy
14,230
+9,059
+175% +$546K 0.01% 580
2023
Q4 		$311K Buy
5,171
+298
+6% +$18.9K 0.01% 935
2023
Q3 		$327K Buy
4,873
+369
+8% +$25.6K 0.01% 854
2023
Q2 		$311K Buy
+4,504
New +$294K 0.01% 818
2022
Q4 		– Sell
-8,060
Closed -$329K – 1614
2022
Q3 		$329K Buy
+8,060
New +$378K 0.01% 671

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Old Mission Capital's LEGN Position: Q1 2025 in Review

Old Mission Capital sold out of Legend Biotech (LEGN) in Q1 2025, closing a stake of 15,927 shares — an estimated $518K sold.

Old Mission Capital first reported a position in LEGN in Q3 2022 and held it in 7 quarters. The position peaked at $800K in Q3 2024. 208 funds tracked by Wall St. Rank hold LEGN as of Q1 2025.

  • Old Mission Capital reported no remaining Legend Biotech position as of Q1 2025 after selling out during the quarter.
  • Old Mission Capital sold 15,927 Legend Biotech shares in Q1 2025, an estimated $518K.
  • Old Mission Capital first reported a position in Legend Biotech in Q3 2022 and held it in 7 quarters.
  • Old Mission Capital's Legend Biotech position peaked at $800K in Q3 2024.
  • 208 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2025.

Based on Old Mission Capital's 13F filing for Q1 2025, filed 15 May 2025.